SANGHVI BEAUTY & TECHNOLOGIES PVT. LTD. – Trademark Portfolio
Entity Type: 24
SANGHVI BEAUTY & TECHNOLOGIES PVT. LTD. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MYGLAMM.
sanghvi house, 105/2, shivaji nagar
pune 411005
Showing of trademarks Trademarks
Trademark Classifications
SANGHVI BEAUTY & TECHNOLOGIES PVT. LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does SANGHVI BEAUTY & TECHNOLOGIES PVT. LTD. have?
SANGHVI BEAUTY & TECHNOLOGIES PVT. LTD. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does SANGHVI BEAUTY & TECHNOLOGIES PVT. LTD. file in?
SANGHVI BEAUTY & TECHNOLOGIES PVT. LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 44 (Medical Services). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are SANGHVI BEAUTY & TECHNOLOGIES PVT. LTD.'s most well-known trademarks?
SANGHVI BEAUTY & TECHNOLOGIES PVT. LTD.'s registered trademark portfolio includes well-known marks such as MYGLAMM. These are among 1 currently registered trademark in the portfolio.
What is SANGHVI BEAUTY & TECHNOLOGIES PVT. LTD.'s trademark registration success rate?
SANGHVI BEAUTY & TECHNOLOGIES PVT. LTD. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.